The global pneumatic nebulizers market is estimated to reach USD 1.05 billion by 2023 at 6 percent compound annual growth rate (CAGR), predicts Global Market Insights. Factors like urbanization and increasing number of motor vehicles causing high levels of air pollution have caused increase in allergic diseases and asthma dramatically.
The Global Burden of Diseases Study estimates the total number of asthma patients to be 334 million worldwide. With such high prevalence of respiratory disorders along with a projected increase in the coming years, pneumatic nebulizers market size is set to witness a healthy growth trajectory.
The economic burden and productivity loss associated with respiratory disorders is of growing concern to the governments globally. The presence of a favorable regulatory landscape will drive the global pneumatic nebulizers market. Growing popularity for home care settings, especially among the elderly patients has also fueled growth. Favorable reimbursement scenario and high prevalence of chronic obstructive pulmonary disease are some of the factors forecast to drive the US pneumatic nebulizers market size, while the presence of unmet needs in terms of low-cost treatment, and rising awareness regarding respiratory diseases in the countries of Latin America and MEA has resulted in high growth potential.
Asia-Pacific pneumatic nebulizers market growth is hinged on China, India, and Japan. China is the fastest-growing regional industry witnessing a CAGR of 9.1 percent during the forecast period, followed by India, and Japan, while LATAM growth was driven by Mexico and Brazil.